Wangao Pharmaceutical

Beijing Wangao Pharmaceutical is a comprehensive Chinese pharmaceutical company specializing in the R&D, manufacturing, and commercialization of chemical drugs, with a focus on chronic disease management. Founded in 2003, the company has established a leading position in therapeutic areas such as cardiovascular health, endocrinology, neurology, and gastroenterology. Its product portfolio features several key treatments for hypertension, hyperuricemia, and diabetes that have successfully met stringent consistency evaluation standards in China. Wangao operates a vertically integrated business model, managing the production of both active pharmaceutical ingredients (APIs) and finished dosage forms at its modern facilities in Jiangsu province. In addition to its internal product line, the company provides CDMO services for chemical synthesis and formulation development to domestic and international partners.